Total Payments
$3,384
2024 Payments
$399.39
Companies
26
Transactions
140
Medicare Patients
2,824
Medicare Billing
$445,248
Payment Breakdown by Category
Food & Beverage$3,308 (97.8%)
Education$76.00 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,308 | 138 | 97.8% |
| Education | $76.00 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,215 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $423.39 | 23 | $0 (2023) |
| Genentech USA, Inc. | $360.50 | 13 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $302.51 | 5 | $0 (2024) |
| Medical Device Business Services, Inc. | $112.21 | 1 | $0 (2023) |
| Baxter Healthcare | $105.71 | 3 | $0 (2023) |
| Advanced Respiratory, Inc | $97.70 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $93.10 | 4 | $0 (2023) |
| GENZYME CORPORATION | $71.16 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.83 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.39 | 5 | AstraZeneca Pharmaceuticals LP ($259.89) |
| 2023 | $1,070 | 35 | AstraZeneca Pharmaceuticals LP ($311.85) |
| 2022 | $73.63 | 4 | GlaxoSmithKline, LLC. ($31.26) |
| 2021 | $178.10 | 11 | AstraZeneca Pharmaceuticals LP ($119.12) |
| 2020 | $260.39 | 18 | AstraZeneca Pharmaceuticals LP ($177.16) |
| 2019 | $710.58 | 37 | Genentech USA, Inc. ($208.34) |
| 2018 | $578.63 | 26 | AstraZeneca Pharmaceuticals LP ($199.14) |
| 2017 | $113.42 | 4 | United Therapeutics Corporation ($56.74) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $127.54 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $112.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $122.75 | General |
| Category: Respiratory | ||||||
| 10/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $107.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/28/2023 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $112.21 | General |
| 08/21/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Respiratory | ||||||
| 08/16/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Respiratory | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Respiratory | ||||||
| 08/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 06/27/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 06/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 06/02/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Immunology | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $119.25 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: HFCWO | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 564 | 760 | $258,505 | $67,960 |
| 2022 | 16 | 674 | 959 | $324,694 | $87,986 |
| 2021 | 21 | 788 | 1,217 | $481,145 | $134,775 |
| 2020 | 18 | 798 | 1,341 | $593,829 | $154,526 |
Total Patients
2,824
Total Services
4,277
Medicare Billing
$445,248
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 57 | 135 | $88,583 | $22,320 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 184 | $59,031 | $17,664 | 29.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 82 | $24,507 | $7,678 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $25,668 | $6,438 | 25.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 24 | 39 | $12,765 | $3,280 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $9,808 | $2,320 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 15 | $6,450 | $2,120 | 32.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,002 | $1,813 | 22.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 76 | 77 | $8,543 | $1,382 | 16.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 59 | 60 | $4,848 | $1,218 | 25.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 42 | 43 | $3,683 | $903.24 | 24.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 12 | $5,308 | $425.92 | 8.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 13 | 14 | $574.00 | $204.68 | 35.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 17 | 17 | $735.00 | $192.70 | 26.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 73 | 212 | $137,800 | $36,105 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 167 | $53,106 | $16,511 | 31.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 97 | $28,809 | $7,890 | 27.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 46 | 88 | $28,600 | $7,630 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $27,384 | $7,082 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $10,868 | $2,983 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $7,242 | $2,353 | 32.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 73 | 74 | $6,074 | $1,783 | 29.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 80 | 81 | $7,895 | $1,421 | 18.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 55 | 56 | $4,832 | $1,330 | 27.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 13 | $1,597 | $905.61 | 56.7% |
About Dr. Haresh Patel, M.D
Dr. Haresh Patel, M.D is a Pulmonary Disease healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2011. The National Provider Identifier (NPI) number assigned to this provider is 1104115187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haresh Patel, M.D has received a total of $3,384 in payments from pharmaceutical and medical device companies, with $399.39 received in 2024. These payments were reported across 140 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,308).
As a Medicare-enrolled provider, Patel has provided services to 2,824 Medicare beneficiaries, totaling 4,277 services with total Medicare billing of $445,248. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Chesapeake, VA
- Active Since 03/30/2011
- Last Updated 07/21/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1104115187
Products in Payments
- FASENRA (Drug) $404.45
- DUPIXENT (Biological) $350.64
- FASENRA (Biological) $304.81
- TEZSPIRE (Biological) $278.47
- TRELEGY ELLIPTA (Drug) $219.15
- NUCALA (Biological) $176.10
- Xolair (Biological) $164.95
- BREZTRI (Drug) $100.79
- Esbriet (Biological) $93.87
- XOLAIR (Biological) $68.25
- SMARTVEST (Device) $65.55
- SYMBICORT (Drug) $64.94
- STIOLTO RESPIMAT (Drug) $59.13
- ORENITRAM (Drug) $56.74
- PURIFIED CORTROPHIN GEL (Drug) $54.88
- The Vest System Model 105 Home Care (Device) $49.06
- GLASSIA (Biological) $48.84
- Indigo System (Device) $39.22
- CRESEMBA (Drug) $32.82
- DS BiPAPS AVAPS (Device) $26.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chesapeake
Carlos Silva, M.d, M.D
Pulmonary Disease — Payments: $281,208
Pulmonary Disease $281,208
Manojkumar Patel, Md, MD
Pulmonary Disease — Payments: $12,628
Pulmonary Disease $12,628
Dr. Michelle Perello, Do, DO
Pulmonary Disease — Payments: $3,348
Pulmonary Disease $3,348
Mrs. Vandana Patel, Md, MD
Pulmonary Disease — Payments: $3,037
Pulmonary Disease $3,037
Eric Freeman, Md, MD
Pulmonary Disease — Payments: $2,061
Pulmonary Disease $2,061
Leah Zuniega, Md, MD
Pulmonary Disease — Payments: $1,988
Pulmonary Disease $1,988